Netabolics

Rome, Italy Founded: 2020 • Age: 6 yrs
AI platform simulates cellular biology to aid drug target selection and pharmaceutical RD.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Netabolics

Netabolics is a company based in Rome (Italy) founded in 2020. It operates as a SaaS and B2B. Netabolics offers products and services including Biosimulation Platform and In Silico Drug Target Selection. Netabolics operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

  • Headquarter Rome, Italy
  • Sectors
    Healthcare
    Technology
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Netabolics Srl
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Netabolics

Netabolics offers a comprehensive portfolio of products and services, including Biosimulation Platform and In Silico Drug Target Selection.

Product name locked
Category locked
Primary

AI tool for simulating cellular biology to predict drug effects

Product name locked
Category locked
Locked

Platform for identifying and validating targets in drug development

Funding Insights of Netabolics

Premium access

Detailed funding history for Netabolics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Netabolics

Investments
Premium access

Investment portfolio details for Netabolics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Netabolics

Premium access

Detailed financials for Netabolics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Netabolics Comparisons

Netabolics Primary company
Description
AI platform simulates cellular biology to aid drug target se...
Location
Rome, Italy
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Netabolics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Netabolics

Netabolics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
An agentic AI platform is developed for biomedical research insights.
Locked Locked Locked
AI-powered drug discovery platform for various diseases
Locked Locked Locked
AI-based technology is used for recombinant protein production in therapeutics.
Locked Locked Locked
Antibody therapies are developed through machine learning and synthetic biology.
Locked Locked Locked
AI-based platform for cancer diagnostics and precision medicine is utilized.
Locked Locked Locked
AI platform used for extracting antibody data from scientific papers.
Premium access

Detailed competitors of Netabolics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Netabolics

Premium access

Complete news archive for Netabolics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Netabolics

Netabolics was founded in 2020.

Netabolics is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.

Netabolics is an AI-driven biotech startup based in Rome, Italy, that develops a biosimulation platform using ordinary differential equations and deep reinforcement learning. This technology simulates cellular responses to factors like drugs and genetics, helping identify targets and predict efficacy and toxicity. The company collaborates with academic, industrial, and technological partners to advance drug discovery, focusing on oncology and combination therapies for faster, cost-effective RD.

Netabolics's top competitors include Owkin, Formation Bio and XtalPi.

Netabolics offers Biosimulation Platform and In Silico Drug Target Selection.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available